Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients

Immunology

Volumn 111, Issue 2, 2004, Pages 223-229

  Nagata, Yoshifumi ^a   Inoue, Hiroko ^a   Yamada, Koichi ^a   Higashiyama, Hiroyuki ^a   Mishima, Kenji ^a   Kizu, Yasuhiro ^b   Takeda, Ienaka ^b   Mizuno, Fumio ^c   Hayashi, Yoshio ^d   Saito, Ichiro ^a  

^a TSURUMI UNIVERSITY   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CALMODULIN INHIBITOR; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE ACTIVATION; GENETIC TRANSFECTION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; SALIVA; SALIVARY GLAND; SJOEGREN SYNDROME; VIRUS ACTIVATION;

ADULT; BIOLOGICAL FACTORS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MAP KINASE SIGNALING SYSTEM; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; SALIVA; SALIVARY GLANDS; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VIRAL PROTEINS; VIRUS ACTIVATION;

EID: 10744230819     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0019-2805.2003.01795.x     Document Type: Article

References (49)

1. Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med 1989; 169: 2191-8.
2. Mariette X, Gozlan J, Clerc D, Bisson M, Morinet F. Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjogren's syndrome. Am J Med 1991; 90:286-94.
3. Saito I, Nishimura S, Kudo I, Fox RJ, Moro I. Detection of Epstein-Barr virus and human herpes virus type 6 in saliva from patients with lymphoproliferative diseases by the polymerase chain reaction. Arch Oral Biol 1991; 36:779-84.
4. Fox RI, Pearson G, Vaughan JH. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome. J Immunol 1986; 137:3162-8.
5. Fox RI, Bumol T, Fantozzi R, Bone R, Schreiber R. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjogren's syndrome. Arthritis Rheum 1986; 29:1105-11.
6. Tateishi M, Saito I, Yamamoto K, Miyasaka N. Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell lines obtained from patients with Sjogren's syndrome. Possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis. Arthritis Rheum 1993; 36:827-35.
7. Sullivan JL. Epstein-Barr virus and lymphoproliferative disorders. Semin Hematol 1988; 25:269-79.
8. Inoue N, Harada S, Miyasaka N, Oya A, Yanagi K. Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjogren's syndrome and with rheumatoid arthritis. J Infect Dis 1991; 164:22-8.
9. Yamaoka K, Miyasaka N, Yamamoto K. Possible involvement of Epstein-Barr virus in polyclonal B cell activation in Sjogren's syndrome. Arthritis Rheum 1988; 31:1014-21.
10. Inoue H, Tsubota K, Ono M et al. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome. J Immunol 2001; 166:5801-9.
11. Haneji N, Nakamura T, Takio K et al. Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 1997; 276:604-7.
12. Rickinson AB, Moss DJ, Wallace LE et al. Long-term T-cell-mediated immunity to Epstein-Barr virus. Cancer Res 1981; 41:4216-21.
13. Slaughter L, Carson DA, Jensen FC, Holbrook TL, Vaughan JH. In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects. J Exp Med 1978; 148:1429-34.
14. Countryman J, Miller G. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci USA 1985; 82:4085-9.
15. Rooney CM, Rowe DT, Ragot T, Farrell PJ. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J Virol 1989; 63:3109-16.
16. zur Hausen H, O'Neill FJ, Freese UK, Hecker E. Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 1978; 272:373-5.
17. Faggioni A, Zompetta C, Grimaldi S, Barile G, Frati L, Lazdins J. Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science 1986; 232:1554-6.
18. Takada K. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 1984; 33:27-32.
19. Luka J, Kallin B, Klein G. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 1979; 94:228-31.
20. Meuller-Lantzsch N, Georg B, Yamamoto N, zur Hausen H. Epstein-Barr virus-induced proteins. II. Analysis of surface polypeptides from EBV-producing and -superinfected cells by immunoprecipitation. Virology 1980; 102:401-11.
21. Mueller-Lantzsch N, Georg B, Yamamoto N, zur Hausen H. Epstein-Barr virus-induced proteins. III. Analysis of polypeptides from P3HR-1-EBV- superinfected NC37 cells by immunoprecipitation. Virology 1980; 102:231-3.
22. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994; 79:1137-46.
23. Flamand L, Stefanescu I, Ablashi DV, Menezes J. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol 1993; 67:6768-77.
24. di Renzo L, Altiok A, Klein G, Klein E. Endogenous TGF-beta contributes to the induction of the EBV lytic cycle in two Burkitt lymphoma cell lines. Int J Cancer 1994; 57:914-9.
25. Fox RI, Saito I. Criteria for diagnosis of Sjogren's syndrome. Rheum Dis Clin North Am 1994; 20:391-407.
26. Yanagawa T, Hayashi Y, Nagamine S, Yoshida H, Yura Y, Sato M. Generation of cells with phenotypes of both intercalated duct-type and myoepithelial cells in human parotid gland adenocarcinoma clonal cells grown in athymic nude mice. Virchows Arch B Cell Pathol Incl Mol Pathol 1986; 51:187-95.
27. Flemington E, Speck SH. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol 1990; 64:1227-32.
28. Flemington E, Speck SH. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol 1990; 64:1217-26.
29. Mellinghoff I, Daibata M, Humphreys RE, Mulder C, Takada K, Sairenji T. Early events in Epstein-Barr virus genome expression after activation, regulation by second messengers of B cell activation. Virology 1991; 185:922-8.
30. Daibata M, Speck SH, Mulder C, Sairenji T. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin- treated B cells. Virology 1994; 198:446-54.
31. Fox PC, Grisius MM, Bermudez DK, Sun D. Cytokine mRNA expression in labial salivary glands and cytokine secretion in parotid saliva in Sjogren's syndrome. Adv Exp Med Biol 1998; 438:909-15.
32. Fox PC, Brennan M, Di Sun P. Cytokine expression in human labial minor salivary gland epithelial cells in health and disease. Arch Oral Biol 1999; 44 (Suppl. 1):S49-52.
33. Fahmi H, Cochet C, Hmama Z, Opolon P, Joab I. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway. J Virol 2000; 74:5810-8.
34. Morgan DG, Niederman JC, Miller G, Smith HW, Dowaliby JM. Site of Epstein-Barr virus replication in the oropharynx. Lancet 1979; 2:1154-7.
35. Chang RS, Lewis JP, Abildgaard CF. Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. N Engl J Med 1973; 289:1325-9.
36. Niller HH, Salamon D, Uhlig J et al. Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes. J Virol 2002; 76:4113-8.
37. Farrell PJ, Rowe DT, Rooney CM, Kouzarides T. Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-I site and is related to c-fos. EMBO J 1989; 8:127-32.
38. Shimizu N, Takada K. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence. J Virol 1993; 67:3240-5.
39. Daibata M, Mellinghoff I, Takagi S, Humphreys RE, Sairenji T. Effect of genistein, a tyrosine kinase inhibitor, on latent EBV activation induced by cross-linkage of membrane IgG in Akata B cells. J Immunol 1991; 147:292-7.
40. Liang CL, Chen JL, Hsu YP, Ou JT, Chang YS. Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins. J Biol Chem 2002; 277:23345-57.
41. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390:465-71.
42. Hocevar BA, Brown TL, Howe PH. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 1999; 18:1345-56.
43. Wang W, Zhou G, Hu MC, Yao Z, Tan TH. Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction. J Biol Chem 1997; 272:22771-5.
44. Hannigan M, Zhan L, Ai Y, Huang CK. The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils. Biochem Biophys Res Commun 1998; 246:55-8.
45. Yamaguchi K, Shirakabe K, Shibuya H et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 1995; 270:2008-11.
46. Davies AH, Grand RJ, Evans FJ, Rickinson AB. Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C. J Virol 1991; 65:6838-44.
47. Halstead J, Kemp K, Ignotz RA. Evidence for involvement of phosphatidylcholine-phospholipase C and protein kinase C in transforming growth factor-beta signaling. J Biol Chem 1995; 270:13600-3.
48. Suzuki M, Asplund T, Yamashita H, Heldin CH, Heldin P. Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-beta 1 involves activation of protein kinase C. Biochem J 1995; 307:817-21.
49. Fox RI, Kang HI, Ando D, Abrams J, Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome. J Immunol 1994; 152:5532-9.